Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
Recently, several different models of 125I and 103Pd brachytherapy sources have been introduced in order to meet the increasing demand for prostate seed implants. These sources have different internal structures; hence, their TG-43 dosimetric parameters are not the same. In this study, the effects of the dosimetric differences among the sources on their clinical applications were evaluated. The quantitative and qualitative evaluations were performed by comparisons of dose distributions and dose volume histograms of prostate implants calculated for various designs of 125I and 103Pd sources. These comparisons were made for an identical implant scheme with the same number of seeds for each source. The results were compared with the Amersham model 6711 seed for 125I and the Theragenics model 200 seed for 103Pd using the same implant scheme.
Meigooni
Ali S
AS
Department of Radiation Medicine, North Shore University Hospital, Manhasset, New York 11030, USA. alimeig@gmail.com
Luerman
Christine M
CM
Sowards
Keith T
KT
D000388:Air; D000465:Algorithms; D001918:Brachytherapy / Q000379:methods*; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007457:Iodine Radioisotopes / Q000494:pharmacology*; D008297:Male; D010165:Palladium / Q000494:pharmacology*; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011868:Radioisotopes / Q000494:pharmacology*; D011874:Radiometry / Q000379:methods; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D015203:Reproducibility of Results
D007457:Iodine Radioisotopes; D011868:Radioisotopes; D010165:Palladium